Atricure Stock Alpha and Beta Analysis

ATRC Stock  USD 30.49  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AtriCure. It also helps investors analyze the systematic and unsystematic risks associated with investing in AtriCure over a specified time horizon. Remember, high AtriCure's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AtriCure's market risk premium analysis include:
Beta
1.4
Alpha
0.0616
Risk
3.17
Sharpe Ratio
0.0535
Expected Return
0.17
Please note that although AtriCure alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, AtriCure did 0.06  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of AtriCure stock's relative risk over its benchmark. AtriCure has a beta of 1.40  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. At present, AtriCure's Tangible Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 3.76, whereas Enterprise Value Over EBITDA is projected to grow to (192.48).

Enterprise Value

54.87 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History and analyze AtriCure Performance.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

AtriCure Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AtriCure market risk premium is the additional return an investor will receive from holding AtriCure long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AtriCure. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AtriCure's performance over market.
α0.06   β1.40

AtriCure expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AtriCure's Buy-and-hold return. Our buy-and-hold chart shows how AtriCure performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

AtriCure Market Price Analysis

Market price analysis indicators help investors to evaluate how AtriCure stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AtriCure shares will generate the highest return on investment. By understating and applying AtriCure stock market price indicators, traders can identify AtriCure position entry and exit signals to maximize returns.

AtriCure Return and Market Media

The median price of AtriCure for the period between Fri, Sep 27, 2024 and Thu, Dec 26, 2024 is 31.54 with a coefficient of variation of 11.26. The daily time series for the period is distributed with a sample standard deviation of 3.6, arithmetic mean of 31.94, and mean deviation of 3.3. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
AtriCure Inc Shares Up 21.47 percent on Oct 30
10/30/2024
2
A Piece Of The Puzzle Missing From AtriCure, Inc.s 28 percent Share Price Climb
11/06/2024
3
AtriCure to Participate in the Stifel 2024 Healthcare Conference
11/07/2024
4
Spolenost VentureOne ze skupiny ATRC pedstavuje na veletrhu CyberQ projekt QuantumGate pro zabezpeen dat pro kvantovou ru
11/14/2024
5
Disposition of 4417 shares by Dahlquist Karl S. of AtriCure at 44.83 subject to Rule 16b-3
11/15/2024
6
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/20/2024
7
PDT Partners LLC Invests 665,000 in AtriCure, Inc.
12/03/2024
8
Fmr LLC Has 27.30 Million Stock Position in AtriCure, Inc. - MarketBeat
12/10/2024
9
Disposition of 585 shares by Justin Noznesky of AtriCure subject to Rule 16b-3
12/11/2024
10
Is AtriCure Using Debt In A Risky Way
12/24/2024

About AtriCure Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AtriCure or other stocks. Alpha measures the amount that position in AtriCure has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding43.9447.1748.057.2
PTB Ratio6.484.443.553.76

AtriCure Upcoming Company Events

As portrayed in its financial statements, the presentation of AtriCure's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AtriCure's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AtriCure's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AtriCure. Please utilize our Beneish M Score to check the likelihood of AtriCure's management manipulating its earnings.
20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with AtriCure

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History and analyze AtriCure Performance.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AtriCure technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AtriCure trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...